Cancer Diagnostics Tests India
Cancer is a broad term used for a group of illnesses that occur when abnormal cells split fast and start spreading to other tissues and organs. It is widely accepted that cancer is the one of the main reasons for death in the world. If you suspect that you might be suffering from cancer then getting a Cancer Test is the best way to determine and clearly diagnose your condition. It is an extremely simple process to book a Cancer Test in Mumbai and get the screening done without any hassles. A Cancer Test that is specific to the kind of symptoms you might be experiencing can help in diagnosing this serious illness and help you in getting the necessary treatment so that you can fight it. A Cancer Test in Mumbai is generally a blood test that can help in diagnosing which kind of cancer you might be suffering from so that correct treatment can be administered. The Cancer Test sample is taken by the phlebotomist by taking a small amount of blood from your vein. The sample is then sent to the lab to perform the test specific to the Cancer Test package you have chosen.
Target BRCA
BRCA 1 and BRCA 2 only
Target Germline
focused genetic test analyzing 163 genes (including BRCA1 and BRCA2) which are associated with elevated risk for 11 most common hereditary cancers and 14 cancer syndromes (associated with multiple cancer types).
Family Testing Germline +
For the family members and close relatives of the Mutation positive patients
Target HRR Germline
All the 15 HRR genes including BRCA 1&2
Target HRR Somatic
All the 15 HRR genes including BRCA 1&2
Target HRR Combo (Block + Blood)
All the 15 HRR genes including BRCA 1&2
Target Lung Liquid (Advance)
EGFR, KRAS, BRAF, ERBB2, ALK, ROS1, RET, MET exon 14 skipping, NTRK1, NTRK2, NTRK3, NRG1, NRG2, FGFR2, FGFR3
Target First
Target First is an affordable targeted 72 gene panel test which identifies gene variants (SNV’s CNV’s and gene fusions) in well curated tumor biomarkers associated with treatment options.
Target First + PDL-1
Target First is an affordable targeted 72 gene panel test which identifies gene variants(SNV’s CNV’s and gene fusions) in well curated tumor biomarkers associated with treatment options. + PDL-1 by IHC
Target First + MSI + PDL-1
Target First is an affordable targeted 72 gene panel test which identifies gene variants(SNV’s CNV’s and gene fusions) in well curated tumor biomarkers associated with treatment options. + PDL-1 by IHC
Target First Liquid
Target First is an affordable targeted 72 gene panel test which identifies gene variants(SNV’s CNV’s and gene fusions) in well curated tumor biomarkers associated with treatment options. Gene fusions (ALK, ROS1, RET, MET EXON 14 SKIPPING, NTRK1,NTRK2, NTRK3, FGFR2, FGFR3, NRG1 and NRG2 )
Target First Pro (Block + Blood)
Target First is an affordable targeted 72 gene panel test which identifies gene variants(SNV’s CNV’s and gene fusions) in well curated tumor biomarkers associated with treatment options. Gene fusions (ALK, ROS1, RET, MET EXON 14 SKIPPING, NTRK1,NTRK2, NTRK3, FGFR2, FGFR3, NRG1 and NRG2 ) .
Target Core + PDL-1
Target Core is an affordable targeted 190 gene panel test which identifies gene variants (SNV’s, Indels, CNVs and gene fusions) in well curated tumor biomarkers associated with treatment options. TARGET-CORE provides insights on actionable and targetable mutations to personalize the cancer treatment + PDL-1 by IHC
Target Core + MSI + PDL-1
Target Core is an affordable targeted 190 gene panel test which identifies gene variants (SNV’s, Indels, CNVs and gene fusions) in well curated tumor biomarkers associated with treatment options. TARGET-CORE provides insights on actionable and targetable mutations
Target Indiegene
Target Indiegene is the world’s first Indian population specific gene panel. It is a pan Cancer panel which profiles DNA/RNA alterations in 1212 genes along with TMB, MSI and PDL-1, True somatic analysis is performed by providing germline analysis for the variants using gDNA from blood .
Target Indiegene (Liquid Biopsy)
Target Indiegene is the world’s first Indian population specific gene panel. It is a pan Cancer panel which profiles DNA/RNA alterations in 1212 genes along with SNVs, CNVs, In-Dels, and Gene Fusions.
Target Indiegene Pro
1) It is a pan solid cancer panel which profiles FFPE DNA/RNA alterations in 1212 genes along with Immunotherapy Biomarkers (TMB, MSI, PDL1). 2) True somatic analysis is performed by providing germline analysis for the variants using gDNA from blood 3) Liquid biopsy using ctDNA on 1212 genes including fusion analysis (ALK, ROS1, RET, MET EXON 14 SKIPPING) AND MSI
TARGET Absolute
Whole exome based comprehensive molecular profiling of Somatic biomarkers including variants all somatic variants SNVs, CNVs, In in both DNA and RNA. Additionally, the test report also includes analysis and interpretation of Immuno Oncology markers - Tumor mutation burden (TMB), Microsatellite Instability .
Target Absolute Plus
Whole exome based comprehensive molecular profiling of Somatic biomarkers including variants all somatic variants SNVs, CNVs, In in both DNA and RNA.
Target Absolute Pro (FFPE Block + 20 ml Streck Tube Blood
1) Whole Exome DNA analysis on 20,000+ genes to cover SNVs/InDels,Copy Number Alterations, MSI, TMB and PDL1 2) Whole Exome RNA analysis on 20,000+ genes to detect and map comprehensive gene fusion landscape
-
- .
250+
Oncologists & Therapists
98.7+
Customer satisfaction
1000+
Cancer Awareness & Screening
100+
Cancer Care Network
Cancer Care Support Line
The Trusted Beacon of Excellence in Cancer Care